Loading clinical trials...
Loading clinical trials...
Comparative, Case Control, Mono-center PMCF Study on Manual and Navigated Revision Knee Patients After a Minimum Follow-Up of Two Years
The Columbus® Revision endoprosthetic system is bearing the CE-mark. This means that within the scope of this observational study the patient will not be subjected to any additional stressful, study-related medical examinations or treatment measures. The treatment will be carried out exclusively according to medical standards. The study therefore only serves the purpose of observing this standard-compliant treatment and specifically documenting it scientifically.
The study's main purpose is the collection of clinical data on the safety and performance of the Columbus® Revision Knee endoprosthesis
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Hospital Universitario Cruces
Barakaldo, Bizkaia, Spain
Start Date
March 16, 2022
Primary Completion Date
June 16, 2023
Completion Date
March 24, 2024
Last Updated
August 14, 2025
100
ACTUAL participants
Navigated Revision Total Knee Arthroplasty
DEVICE
Manual Revision Total Knee Arthroplasty
DEVICE
Lead Sponsor
Aesculap AG
Collaborators
NCT07351968
NCT06747494
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06906939